Mathematical models of lipoprotein metabolism and kinetics: current status and future perspective

Abstract Lipoprotein metabolism and kinetics comprises the time-dependent processes of synthesis, transformation and clearance of lipids, apolipoproteins and their assembled particles. By integrating and explaining the wealth of in vitro and clinical data available on lipoprotein metabolism and kinetics, mathematical models can provide novel insights into the underlying pathophysiology of lipid disorders, as well as quantify the effects of drugs intended for their treatment. In this article, we first discuss some basic principles of mathematical modeling in biology and drug development, and then review a number of recent publications in which different types of mathematical models have been used to investigate lipoprotein metabolism and kinetics. We conclude by posing a set of ten fundamental questions in this field that we believe mathematical modeling can potentially address, in the effort to develop novel and effective therapies for patients with high cardiovascular risk.

[1]  M. Krempf,et al.  New model for kinetic studies of HDL metabolism in humans , 2004, European journal of clinical investigation.

[2]  Samia Mora,et al.  A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study. , 2013, Clinical chemistry.

[3]  Samuel Kaski,et al.  High Density Lipoprotein Structural Changes and Drug Response in Lipidomic Profiles following the Long-Term Fenofibrate Therapy in the FIELD Substudy , 2011, PloS one.

[4]  Daniël B. van Schalkwijk,et al.  Diagnostic markers based on a computational model of lipoprotein metabolism , 2011, Journal of Clinical Bioinformatics.

[5]  A. Zwinderman,et al.  Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins , 2008, Current medical research and opinion.

[6]  T Magot,et al.  A new labeling approach using stable isotopes to study in vivo plasma cholesterol metabolism in humans. , 2002, Metabolism: clinical and experimental.

[7]  Friedrich C. Luft,et al.  A pathway model of lipid metabolism to predict the effect of genetic variability on lipid levels , 2000, Journal of Molecular Medicine.

[8]  A. Kontush,et al.  Lipidomics as a Tool for the Study of Lipoprotein Metabolism , 2010, Current atherosclerosis reports.

[9]  P Hugh R Barrett,et al.  Thematic Review What We Have Learned about Vldl and Ldl Metabolism from Human Kinetics Studies , 2022 .

[10]  Hiroaki Kitano,et al.  CellDesigner: a process diagram editor for gene-regulatory and biochemical networks , 2003 .

[11]  P Hugh R Barrett,et al.  Thematic review series: Patient-Oriented Research. Design and analysis of lipoprotein tracer kinetics studies in humans Published, JLR Papers in Press, May 25, 2006. , 2006, Journal of Lipid Research.

[12]  Jacob D. Durrant,et al.  Molecular dynamics simulations and drug discovery , 2011, BMC Biology.

[13]  P. Meikle,et al.  Lipidomics is providing new insight into the metabolic syndrome and its sequelae , 2011, Current opinion in lipidology.

[14]  M. Berman,et al.  Multicompartmental analysis of cholesterol metabolism in man. Quantitative kinetic evaluation of precursor sources and turnover of high density lipoprotein cholesterol esters. , 1982, The Journal of clinical investigation.

[15]  Jianwen Fang,et al.  Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes , 2008, Proceedings of the National Academy of Sciences.

[16]  Ph.D. James E. A. McIntosh M.A.,et al.  Mathematical Modelling and Computers in Endocrinology , 1980, Monographs on Endocrinology.

[17]  Jeffrey H. Chuang,et al.  Dynamic simulation of cardiolipin remodeling: greasing the wheels for an interpretative approach to lipidomics[S] , 2010, Journal of Lipid Research.

[18]  D. Rader,et al.  The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans. , 2010, Atherosclerosis.

[19]  G. Lewis,et al.  Thematic review series: Patient-Oriented Research. What have we learned about HDL metabolism from kinetics studies in humans? Published, JLR Papers in Press, May 9, 2006. , 2006, Journal of Lipid Research.

[20]  Hermann-Georg Holzhütter,et al.  Computational Lipidology: Predicting Lipoprotein Density Profiles in Human Blood Plasma , 2008, PLoS Comput. Biol..

[21]  C Cobelli,et al.  SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. , 1998, Metabolism: clinical and experimental.

[22]  Charles C Schwartz,et al.  Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200 , 2004, Journal of Lipid Research.

[23]  Ilpo Vattulainen,et al.  Role of Lipids in Spheroidal High Density Lipoproteins , 2010, PLoS Comput. Biol..

[24]  D. Rader,et al.  Targeting High Density Lipoproteins in the Prevention of Cardiovascular Disease? , 2012, Current Cardiology Reports.

[25]  Sven Sahle,et al.  Computational modeling of biochemical networks using COPASI. , 2009, Methods in molecular biology.

[26]  A. D. de Graaf,et al.  Clustering by Plasma Lipoprotein Profile Reveals Two Distinct Subgroups with Positive Lipid Response to Fenofibrate Therapy , 2012, PloS one.

[27]  F. Tobin,et al.  Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro , 2009, Journal of Lipid Research.

[28]  Darren J. Wilkinson,et al.  A whole-body mathematical model of cholesterol metabolism and its age-associated dysregulation , 2012, BMC Systems Biology.

[29]  A. D. de Graaf,et al.  Computational models for analyzing lipoprotein profiles , 2011 .

[30]  Sven Sahle,et al.  Applications and trends in systems biology in biochemistry , 2011, The FEBS journal.

[31]  Matej Oresic,et al.  Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles , 2007, ISMB/ECCB.

[32]  Ben van Ommen,et al.  A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans[S] , 2012, Journal of Lipid Research.

[33]  D. H. Gregory,et al.  Multicompartmental analysis of cholesterol metabolism in man. Characterization of the hepatic bile acid and biliary cholesterol precursor sites. , 1978, The Journal of clinical investigation.

[34]  S. Nicholls,et al.  The emerging role of plasma lipidomics in cardiovascular drug discovery , 2012, Expert opinion on drug discovery.

[35]  B. Shen,et al.  Structure of human serum lipoproteins inferred from compositional analysis. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. Curtiss,et al.  Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma , 2010, Nature Structural &Molecular Biology.

[37]  S. Turner,et al.  Measurement of Reverse Cholesterol Transport Pathways in Humans: In Vivo Rates of Free Cholesterol Efflux, Esterification, and Excretion , 2012, Journal of the American Heart Association.

[38]  S. Hazen,et al.  The Low Resolution Structure of ApoA1 in Spherical High Density Lipoprotein Revealed by Small Angle Neutron Scattering* , 2011, The Journal of Biological Chemistry.

[39]  Markus Abt,et al.  Effects of dalcetrapib in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.